Alamar Biosciences, Inc.
ALMR- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0002104204
In the last 90 days, Alamar Biosciences, Inc. insiders filed 0 open-market purchases and 7 sales; 87 institutions reported holding it in 13F filings for Q2 2026, worth $664.3M in total; 3 superinvestors hold it, including ARK Invest and HHLR Advisors (Hillhouse).
Key figures
- Market capClose on Nov 10, 2026
- $2.19B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $44.6M in total
- 7
- 13F holdersQ2 2026, +87 vs. previous quarter
- 87
- 13F valueReported value at the end of Q2 2026
- $664.3M
- Superinvestors holdingAt the end of Q2 2026
- 3
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, Q3 FY2026
- $33.5M
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.24M
- Shares sold short
- Change
- −433.3K
- −16.2% vs. previous
- Days to cover
- 3.27
- At average daily volume
Superinvestors holding ALMR, Q2 2026
Go to the superinvestors tab3 superinvestors report holding Alamar Biosciences, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
ARK Invest
Cathie Wood
0.2%
Alamar Biosciences, Inc.'s share of the portfolio
- Shares
- 1,373,959
- Value
- $37.2M
HHLR Advisors (Hillhouse)
Zhang Lei
3.1%
Alamar Biosciences, Inc.'s share of the portfolio
- Shares
- 956,462
- Value
- $25.9M
| Superinvestor | Weight | Value |
|---|---|---|
| Soros Fund Management | <0.1% | $1.63M |
Latest insider trades
See all insider tradesOpen-market purchases and sales by Alamar Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)4:10 PM ET | Nov 3 | 2 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −111.3K | $29.89 | −$3.33M | −6.3%1.65M after | 4 lots |
| Nov 3, 2026 (view filing)4:15 PM ET | Oct 30-Nov 2 | 4 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −187.6K | $30.25 | −$5.68M | −10.1%1.67M after | 24 lots |
| Oct 29, 2026 (view filing)4:09 PM ET | Oct 27-28 | 2 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −185.7K | $32.14 | −$5.97M | −9.8%1.70M after | 20 lots |
| Oct 27, 2026 (view filing)4:10 PM ET | Oct 23-26 | 4 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −280.5K | $30.56 | −$8.57M | −13.9%1.74M after | 20 lots |
| Oct 23, 2026 (view filing)7:35 PM ET | Oct 21-22 | 2 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −342.6K | $29.93 | −$10.3M | −16.1%1.79M after | 24 lots |
| Oct 21, 2026 (view filing)7:15 PM ET | Oct 19-20 | 2 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −217.5K | $27.35 | −$5.95M | −10.5%1.85M after | 16 lots |
| Oct 19, 2026 (view filing)4:30 PM ET | Oct 15-16 | 4 days | Qiming Venture Partners VI, L.P. and 6 others10% Owner | SSale | −173.7K | $27.73 | −$4.82M | −8.4%1.89M after | 12 lots |
| Apr 20, 2026 (view filing)8:45 PM ET | Apr 20 | Same day | Naclerio Nicholas and 4 others10% Owner | PPurchase | +235.3K | $17.00 | +$4.00M | +86.6%507.1K after | Duplicate filing |
| Apr 20, 2026 (view filing)8:31 PM ET | Apr 20 | Same day | Naclerio NicholasDirector | PPurchase | +235.3K | $17.00 | +$4.00M | +86.6%507.1K after |
Top 10 13F holders, Q2 2026
See all 87 holdersThe largest institutional positions in Alamar Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 4,230,926 | $114.6M | 18.68% | +4,230,926 | New |
| Samsara BioCapital, LLC | 2,480,310 | $67.2M | 5.52% | +2,480,310 | New |
| T. Rowe Price Investment Management, Inc. | 2,202,597 | $59.7M | 0.04% | +2,202,597 | New |
| ARK Investment Management LLCSuperinvestorARK Invest | 1,373,959 | $37.2M | 0.24% | +1,373,959 | New |
| Braidwell LP | 1,083,983 | $29.4M | 1.09% | +1,083,983 | New |
| Alliancebernstein L.P. | 1,003,077 | $27.2M | 0.01% | +1,003,077 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 956,462 | $25.9M | 3.11% | +956,462 | New |
| BlackRock, Inc. | 911,445 | $24.7M | 0.00% | +911,445 | New |
| Millennium Management LLC | 865,764 | $23.5M | 0.02% | +865,764 | New |
| FMR LLC | 829,424 | $22.5M | 0.00% | +829,424 | New |
Holders of 5% or more of ALMR
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Alamar Biosciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. | 13G | 10.20%7.07M shares | New | Aug 11, 20261 filing | Aug 11, 2026 | SEC |
| Illumina Innovation Fund II, L.P. | 13D | 9.60%6.36M shares | New | Apr 23, 20261 filing | Apr 23, 2026 | SEC |
| Sherpa Healthcare Fund II, L.P. | 13G | 7.20%4.97M shares | New | Jul 2, 20261 filing | Jul 2, 2026 | SEC |
| Luo Yuling | 13G | 6.40%4.53M shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 13D/A | 6.10%4.23M shares | −0.20 ppfrom 6.30% | Apr 23, 20262 filings | Jul 7, 2026 | SEC |